ライフサイエンスコーパス: phosphate buffer

1 itions using different organic solvents with phosphate buffer.

2 ble to compete with loss of uracil from 1 in phosphate buffer.

3 of adding a glucose solution to a potassium phosphate buffer.

4 S-ssDNA and hybridization sensing is done in phosphate buffer.

5 nge is possible in neutral and mildly acidic phosphate buffer.

6 c, and near 100% Faradaic efficiency in pH 7 phosphate buffer.

7 constant (K(d)) value of 0.95 nM in neutral phosphate buffer.

8 as well as with hydrogen peroxide in aqueous phosphate buffer.

9 c antigen (PSA) from 1 to 1,000 nM in 100 mM phosphate buffer.

10 of detection (LOD) of 1.575 ng/mL (5 nM) in phosphate buffer.

11 n fructose and glucose solutions prepared in phosphate buffer.

12 pH, oxygen concentration and the presence of phosphate buffer.

13 y, were modified by incubation with iron and phosphate buffers.

14 - 0.09 and 4.6 +/- 0.7 mM measured in MES or phosphate buffers.

15 120days of storage at 4 degrees C in sodium phosphate buffer (0.1M, pH 7.5), whereas the free trypsi

16 roteins: 2.0 x10(-4) cm(3)mol/g(2) for Mb in phosphate buffer, 1.6 x10(-4) cm(3)mol/g(2) for BPTI in

17 ixture consisting in acetonitrile and sodium phosphate buffer 10mmolL(-1) pH = 3.50 (30:70v/v).

18 Phosphate buffer 44mM pH 2.5, containing 8% tetrahydrofu

19 red at -0.7 V vs Ag reference electrode in a phosphate buffer (50 mM, pH 7.0).

20 n at -0.7V vs. the Ag reference electrode in phosphate buffer (50mM, pH 6.0).

21 mbrane-less, miniature BFC were obtained: in phosphate buffer; an open-circuit voltage of 0.68 V, a m

22 uffer, 1.6 x10(-4) cm(3)mol/g(2) for BPTI in phosphate buffer and 9.2 x10(-4) cm(3)mol/g(2) for BPTI

23 nd 1-hydroxypyrene-glucuronide (1-pyOglu) in phosphate buffer and artificial urine.

24 of each diastereomer was studied in aqueous phosphate buffer and in CEM/0 cell extracts.

25 lpha-Cbtx, and the pellet was dissolved in a phosphate buffer and mixed with methanol for precipitati

26 fugation, and mixing of the supernatant with phosphate buffer and sodium cyanide for derivatization i

27 , TRIS, MES, sodium phosphate, and potassium phosphate buffers, and found that PBS and MES buffers ar

28 ater oxidation catalysis with involvement of phosphate buffer anions either through atom-proton trans

29 cular rate constant of HNO with PY in pH 7.4 phosphate buffer at 37 degrees C can reach 8 x 10(5) M(-

30 ll cases, reactions proceeded efficiently in phosphate buffer at a physiological pH and at low substr

31 ha-l- or beta-alanine and l-valine in pH 7.0 phosphate buffer at ca. 100 degrees C.

32 The sensor was calibrated for MTX in phosphate buffer at different dynamic range by varying n

33 anut, carbonate buffer at I=0.15 for almond, phosphate buffer at I=0.5 for hazelnut, and borate at I=

34 eta with incubation of complexes (0-24 h) in phosphate buffer at micromolar concentrations.

35 conversion of azides into diazo compounds in phosphate buffer at neutral pH and room temperature.

36 , efficiently catalyzes water oxidation in a phosphate buffer at pH 11 at room temperature by a well-

37 ent containing 40% acetonitrile (v/v), 20 mM phosphate buffer at pH 3 and 40 mM NaPF(6) using externa

38 ntial of 0.1 V (vs. Ag/AgCl, 3 M) in a 0.2 M phosphate buffer at pH 6.0.

39 r oil (CLO) and metmyoglobin (metMb) in 50mM phosphate buffer at pH 6.0.

40 approximately 90-mW/cm(2) illumination in a phosphate buffer at pH 7.

41 as achieved within only 2 min using 20 mM of phosphate buffer at pH 7.0 and 30 mM of sodium dodecyl s

42 osone 2 (D-arabino-hexos-2-ulose) in aqueous phosphate buffer at pH 7.5 and 37 degrees C have been in

43 on screen-printed electrode (SPE) in a 0.11M phosphate buffer at pH 7.50.

44 that of the running buffer (12.5 mmol L(-1) phosphate buffer at pH 8.5).

45 e is incubated in pH 3.0 of 0.10 M potassium phosphate buffer-based cocktail containing aniline, H2O2

46 ed strongly vitamin C degradation in citrate-phosphate buffer but not in the apple puree serum.

47 rds cardiac troponin I [1.7microA/(ng/mL) in phosphate buffer], but suffered from surface fouling in

48 m reaction conditions were at pH 7.5 using a phosphate buffer concentration of 150 mmol l(-1) without

49 A pH span of 3-12 was attained and a phosphate buffer concentration up to 140 mM was generate

50 nochloramine and bromide ion concentrations, phosphate buffer concentration, and excess ammonia were

51 biocathode and GC/MWCNTs/GOx/PPy bioanode in phosphate buffer containing 10mM glucose and equal amoun

52 ight of the proteins extracted with a sodium phosphate buffer containing 2.0% sodium dodecyl sulfate

53 ied on a Ni(+2) column and eluted with 50 mM phosphate buffer containing 500 mM NaCl and 250 mM imida

54 treated shrimp increased significantly when phosphate buffer containing both surfactant and reducing

55 ne (NDMA) formation experiments conducted in phosphate buffer demonstrated that in waters containing

56 sitivity as the corresponding viral titer in phosphate buffer despite the presence of growth media an

57 ontrast, the scattering profiles for BPTI in phosphate buffer displayed substantially less pronounced

58 ation of hydrazine, N(2)H(4), in a deaerated phosphate buffer electrolyte (pH 7) on Au, a process kno

59 trodeposition of cobalt oxide materials from phosphate-buffered electrolyte solutions.

60 one (HQ) and Hydrogen peroxide (H2O2) in PB (Phosphate Buffer) electrolyte.

61 ion from 20 to 120 nM in high ionic strength phosphate-buffered fluoride (PBF) buffer, yielding a lim

62 luted in either phosphate-buffered saline or phosphate buffer, has been widely used in studies of neu

63 meter silica nanoparticles) was incubated in phosphate buffer in the presence of the solid-phase.

64 erformance than sodium phosphate and citrate-phosphate buffers in IMAC system.

65 inactivation of B. subtilis spores in 10 mM phosphate buffer; increasing inactivation rate constants

66 chloride-induced unfolded ensemble in dilute phosphate buffer involves kinetic partitioning: one frac

67 channel filled with citric acid and disodium phosphate buffers is investigated via numerical simulati

68 Sudan I on modified GCE was investigated in phosphate buffer medium (PBS) with various pH ranges and

69 eutral to slightly acidic pH in 10 mM sodium phosphate buffer, mitigating the concern of disassembly

70 In pH 7 phosphate buffer, Ni3S2 displays catalytic onset at 0.8

71 g the sensor combining TMB, H2O2, and GBR in phosphate buffer of pH 4.48, the S(2-) ion has effective

72 Using low acidity (pH=2.5 set by phosphate buffers) only 3% of 9-xanthyl ethyl carbamate

73 amine (GlcN, 5% w/v) was incubated in either phosphate buffer or ammonium hydroxide solutions at 40 a

74 ochloramine in secondary wastewater (WW) and phosphate buffer (PB) as assessed by reverse transcripti

75 ups: (1) a control group that received 100mM phosphate buffer (PB) ig and 0.9% saline ip, (2) PB+HgCl

76 bacteriophage in secondary effluent MWW and phosphate buffer (PB).

77 l with 1,6-hexane-bis-vinylsulfone (HBVS) in phosphate buffer (PB, pH 7.4) containing 0.1% v/v Tween

78 fication provided by 15 mM hydrazine in 5 mM phosphate buffer (PB; pH 7) over 100 to 300 s.

79 ate, TPPS, with Ka=3.8 10(5)mol/L in aqueous phosphate buffer pH 5.7 at 30 degrees C, and to interact

80 2O) concentrations and buffers/pH (potassium phosphate buffer pH 6-8, Tris buffer pH 8-10) on the cur

81 these compounds at room temperature using a phosphate buffer pH 7/CD3CN mixture has shown only trace

82 performed in less than 18 min employing 20mM phosphate buffer (pH 6.5) and 150 mM SDS as background e

83 at potential of -0.1 V (vs. Ag/AgCl, 3 M) in phosphate buffer (pH 7).

84 tion of AgNP dissolution in an air-saturated phosphate buffer (pH 7.0, 25 degrees C) under variable N

85 The responses for Hx were obtained in 0-05 M phosphate buffer (pH 7.1) at 0.0 mV vs Ag/AgCl (3M KCl).

86 ated with the Hg(2)(+) concentrations in the phosphate buffer (pH 7.5, 50 mM).

87 during simulated solar irradiation of 10 mM phosphate buffer (pH 8, 10 degrees C) containing [FAC]0

88 by the faster degradation of curcuminoids in phosphate buffer (pH=6.8) than in buttermilk.

89 mug muL(-1) stock solutions in 100 mM sodium phosphate buffers (pH 1-12) at room temperature.

90 lded a well-defined voltammetric response in phosphate buffer, pH 2.5 at +1.14 V (vs. Ag/AgCl) (a pre

91 , at either neutral or moderately acidic pH (phosphate buffer, pH 5) depending on the catalyst used.

92 ace-confined myoglobin, in a deaerated 0.1 M phosphate buffer, pH 7.

93 duction reaction using cyclic voltammetry in phosphate buffer, pH 7.0, the immunosensor showed excell

94 are stable in physiological conditions (20mM phosphate buffer, pH 7.4, 0.14 M NaCl, 37 degrees C) and

95 The limit of detection was 0.29pg/ml in phosphate buffer saline (PBS) and 1.3pg/ml in mouse brai

96 racies result from using inert media such as phosphate buffer saline (PBS), failing to account for th

97 In a mixed solvent [phosphate buffer saline (PBS), pH = 7.4/ethanol 1:9], th

98 ive layer) mainly aiming dengue diagnosis in phosphate buffer saline and blood serum environments (up

99 terminations by fixed potential amperometry, phosphate buffer saline being the best.

100 latively strong fluorescence in methanol and phosphate buffer saline in the near-infrared region (705

101 f 1.0 mumol of TAPTA per minute in a pH 7.40 phosphate buffer saline solution containing 10% dimethyl

102 Whole blood or phosphate buffer saline spiked with low numbers of pancr

103 ine was examined in electrolyte solutions of phosphate buffer saline, sodium perchlorate, and in chol

104 the effect of different extraction buffers (phosphate buffer saline, Tris-HCl and NaCl) on the extra

105 ng double side tape spacer and StartingBlock phosphate buffer saline- Tween-20; (PBS-T20) blocking bu

106 ng free spaces on surface via starting block phosphate buffer saline-tween20 blocker.

107 using 0.5M NaCl as compared to Tris-HCl and phosphate buffer saline.

108 controlling the concentration of Dulbecco's phosphate buffered saline (DPBS) electrolyte, the double

109 bilized antibodies on the ZnO surface in (i) phosphate buffered saline (PBS) and (ii) human serum.

110 Detection of cTnT in phosphate buffered saline (PBS) and human serum (HS) buf

111 anging from ~10(5) to 3.2 x 10(7) CFUs/mL in phosphate buffered saline (PBS) and peritoneal dialysis

112 hest Q approximately 9300 in the bio-ambient phosphate buffered saline (PBS) as well as highest sensi

113 rene (d(8)-PS) and SiO(2) model surfaces and phosphate buffered saline (PBS) at pH 7.4.

114 ns, and was found to be slowly degradable in phosphate buffered saline (PBS) but more rapidly degrade

115 ound to contain higher TPC, TFC and TCC than phosphate buffered saline (PBS) extracts for all the fru

116 particle loaded gels can release timolol in phosphate buffered saline (PBS) for about a month at roo

117 g was induced in one eye with glutaraldehyde/phosphate buffered saline (PBS) immersion while the othe

118 Incubation of the coated sensors in phosphate buffered saline (PBS) led to a monotonic incre

119 t between phospholipid bilayer membranes and phosphate buffered saline (PBS) medium (DMW,PBS) for 19

120 DF-1) versus a bolus application of SDF-1 in phosphate buffered saline (PBS) on wound healing was eva

121 re injected subcutaneously with bleomycin or phosphate buffered saline (PBS) once daily for 28 days.

122 pended inside a flowing medium that contains phosphate buffered saline (PBS) or whole blood.

123 lly captured and detected HIV-1 in serum and phosphate buffered saline (PBS) samples with viral loads

124 mplification at room temperature in 30min in phosphate buffered saline (PBS) solution.

125 ther with fibrocytes, dermal fibroblasts, or phosphate buffered saline (PBS) through tail vein inject

126 , we explore the effect of concentration for phosphate buffered saline (PBS), a typical ionic medium

127 The films were shown to be stable in phosphate buffered saline (PBS).

128 ch resonances show high Q in the bio-ambient phosphate buffered saline (PBS).

129 ol mice were similarly injected with sterile phosphate buffered saline (PBS).

130 lized on a gold film in both air and flowing phosphate buffered saline (PBS).

131 performed in physiological buffers, such as phosphate buffered saline (PBS).

132 R) at a diffusion-controlled rate in aerated phosphate buffered saline (PBS).

133 ere performed at 37 degrees C in rat plasma, phosphate buffered saline (PBS, pH 7.4) and PB (pH 7.4).

134 release of 23% and 47% bound lactic acid in phosphate buffered saline (PBS, pH7.4) and acetate buffe

135 raarticular injections (50 mul/injection) of phosphate buffered saline (PBS; n = 14 rats) and human s

136 and their critical micelle concentrations in phosphate buffered saline (pH 7.4) are </=85 microg/mL.

137 ately as Hg sources in washed cell assays in phosphate buffered saline (pH 7.4), we report how cell-m

138 in vivo compared to in vitro using agitated phosphate buffered saline +0.02% Tween 80 pH7.4, includi

139 We have calibrated the sensor using phosphate buffered saline and demonstrated trace detecti

140 approximately 5fg/ml for assays conducted in phosphate buffered saline buffer (PBS) and approximately

141 nhancer of viral infection fibrils formed in phosphate buffered saline keep evolving after the initia

142 In phosphate buffered saline medium the actual lipophilicit

143 ysis using a short gel-filtration column and phosphate buffered saline solution as the mobile phase.

144 unction studies, recombinant IL-7 or control phosphate buffered saline was injected intraperitoneally

145 SEB dissolved in phosphate buffered saline was resolved to levels as low

146 LV-1h153 (1 x 10(7) plaque-forming units) or phosphate buffered saline was tested in an orthotopic mu

147 Given time, most of the assemblies in phosphate buffered saline will turn into elongated thin

148 Competition experiments (in 68% DMSO/phosphate buffered saline) using 1 equiv of N-phenethyl-

149 obtained compared to result obtained in PBS (phosphate buffered saline).

150 .0078mg/ml of T24 (Grade III) cell lysate in phosphate buffered saline, artificial urine and human ur

151 cross-sections of brushite cylinders aged in Phosphate Buffered Saline, Foetal Bovine Serum, Dulbecco

152 xhibited excellent analytical performance in phosphate buffered saline, including a NO sensitivity of

153 3-treated P. gingivalis-infected mice versus phosphate buffered saline-treated P. gingivalis-infected

154 25 head and neck squamous carcinoma cells in phosphate buffered saline.

155 tection limit of 500 muM in water and 1mM in phosphate buffered saline.

156 specific and little non-specific binding in phosphate buffered saline.

157 Outflow facility for phosphate-buffered saline (0.0027 +/- 0.00036 muL/min/mm

158 l suspension of liposomes coated with either phosphate-buffered saline (control) or clodronate (a mac

159 bacterial endotoxin contained in Dulbecco's phosphate-buffered saline (DPBS), a cohesive OVD, and a

160 cells at room temperature or 4 degrees C in phosphate-buffered saline (labeling efficiency range, 13

161 In the presence of 5 mM glucose in phosphate-buffered saline (PBS) (50 mM phosphate buffer

162 d in 50 mg/mL TCN solution (experimental) or phosphate-buffered saline (PBS) (control).

163 n of the brain with cold or room temperature phosphate-buffered saline (PBS) also caused significant

164 d -25 degrees C for at least 3 days by using phosphate-buffered saline (PBS) and cysteine/methionine-

165 The detection curves were obtained in phosphate-buffered saline (PBS) and in undiluted artific

166 niae were treated intravenously with PFCE or phosphate-buffered saline (PBS) and then managed in eith

167 tal recoveries obtained for all compounds in phosphate-buffered saline (PBS) and urine samples owing

168 HDP-cyclic-CDV was suspended in phosphate-buffered saline (PBS) at 37 degrees C and form

169 es for the detection of nitric oxide (NO) in phosphate-buffered saline (PBS) at pH 7.4.

170 were injected with cultured mast cells or 1x phosphate-buffered saline (PBS) before collecting serum,

171 pSHEV-1 triple mutant, wild-type pSHEV-3, or phosphate-buffered saline (PBS) buffer (n = 10).

172 Hydrolysis in pH 5.5 Mes and pH 7.2 phosphate-buffered saline (PBS) buffers was similar, but

173 -2-infected guinea pigs compared to those of phosphate-buffered saline (PBS) control-vaccinated anima

174 ear in WT-infected mice did not differ from phosphate-buffered saline (PBS) controls or mice infecte

175 A plus Vaxfectin i.m. or 100 mug of DNA plus phosphate-buffered saline (PBS) i.m. using a needleless

176 in the presence of succinate, fumarate, and phosphate-buffered saline (PBS) in different cell models

177 rfusion of Adv.cmv.L-CPT1 (L-CPT1, n=15) vs. phosphate-buffered saline (PBS) infusion (PBS, n=7) or e

178 technique for cell-free virus elution using phosphate-buffered saline (PBS) may provide an alternati

179 p was intravenously injected either with 2mL phosphate-buffered saline (PBS) or 3million hUTC in PBS

180 animals used as controls were injected with phosphate-buffered saline (PBS) or GBV-B, respectively.

181 ue-Dawley rats, 2 microg rhTSG-6 in 5-microL phosphate-buffered saline (PBS) or the same volume of on

182 th a S-OIV clinical isolate concentration in phosphate-buffered saline (PBS) over a range of 18-1.8 x

183 rythrocytes at 37 degrees C for up to 24h in phosphate-buffered saline (PBS) supplemented with 0 to 5

184 plification was achieved through dilution of phosphate-buffered saline (PBS) to tune Cdl to dominate

185 to 400 mg/dL or 0.10-10.34 mmol/L in 100 mM phosphate-buffered saline (PBS) without significant inte

186 reserved in diverse sample matrices, namely, phosphate-buffered saline (PBS), Middlebrook 7H9 medium

187 were attained for all the studied probes in phosphate-buffered saline (PBS), urine, and whole blood.

188 lae were found in their spleens, unlike with phosphate-buffered saline (PBS)-dosed mice, and vaccinat

189 ferritin Ab-functionalized microparticles in phosphate-buffered saline (PBS).

190 tions of VIPhyb (peptidic VIP-antagonist) or phosphate-buffered saline (PBS).

191 r 50 mg/kg per week), nontarget (NT) ASO, or phosphate-buffered saline (PBS).

192 obiota in two frequently used batch systems: phosphate-buffered saline (PBS, oligotrophic) and basal

193 Control animals received phosphate-buffered saline (PBS; n = 5 to 7).

194 usion of either human recombinant decorin or phosphate-buffered saline (vehicle).

195 BALB/c mice received LAIV or phosphate-buffered saline 1 or 7 days before or during p

196 RMG (but not in those vaccinated with REG or phosphate-buffered saline [PBS]) after homologous or het

197 d 2-[(131) I] exhibit good stability in both phosphate-buffered saline and blood serum.

198 t IL-22 or anti-IL-22 neutralizing antibody; phosphate-buffered saline and IgG served as respective c

199 ntly enhanced analytical performance in both phosphate-buffered saline and plasma (6-20x improvement

200 ated mice compared to those in animals given phosphate-buffered saline and then infected with the bac

201 thod is approximately 1 IU/mL (2 nM) in both phosphate-buffered saline and urine samples, and only 0.

202 pyridine analogues were more soluble in both phosphate-buffered saline and water.

203 lated with herpes simplex virus 1 (HSV-1) or phosphate-buffered saline as a control.

204 ells were formed into pellets and covered in phosphate-buffered saline at room temperature for 56 h.

205 ration of TT30 were unaffected by citrate or phosphate-buffered saline buffers and indicate an elonga

206 et for 12 weeks, then administered rIL-19 or phosphate-buffered saline concomitant with Western diet

207 An investigation of drug release kinetics in phosphate-buffered saline containing Tween 80 led us to

208 dose of 20 mg/kg orally twice daily (n=7) or phosphate-buffered saline control (n=6) orally for 7 day

209 The aerosol particles were then dispersed in phosphate-buffered saline for cytotoxicity and senescenc

210 TNNB1-LNP), scrambled sequence (Scr-LNP), or phosphate-buffered saline for multiple cycles.

211 human amniotic mesenchymal stromal cells or phosphate-buffered saline infused intracerebroventricula

212 mucosa between the molars; and 6) group I-V: phosphate-buffered saline injected into the palatal muco

213 Mouse IgG diluted in phosphate-buffered saline is used as model target antige

214 assembly by injection from THF solution into phosphate-buffered saline led to unilamellar, monodisper

215 e injected i.p. with 50 or 250 mg/kg APAP or phosphate-buffered saline on gestation day 12.5; nonpreg

216 individuals by the oral route, mice were fed phosphate-buffered saline or 10(6)M. canettii mycobacter

217 tal fat-derived stem/stromal cells in 50 muL phosphate-buffered saline or 50 muL phosphate-buffered s

218 Phosphate-buffered saline or iPSC-w/o-c-Myc was then int

219 Formaldehyde, diluted in either phosphate-buffered saline or phosphate buffer, has been

220 e, which were challenged with OVA peptide or phosphate-buffered saline or remained untreated.

221 ily dissociated from the graft surface after phosphate-buffered saline rinsing.

222 Mice that received phosphate-buffered saline solution only were included as

223 ide, and the ECL of the 1a film was found in phosphate-buffered saline solution with TPrA.

224 versibility of PRET upon the introduction of phosphate-buffered saline to the channel.

225 regulator PG490-88 (MRx-108; 0.75 mg/kg) or phosphate-buffered saline was administered preventilatio

226 tacept (CTLA4-Ig), etanercept (anti-TNF), or phosphate-buffered saline were given to NMRI mice intrav

227 o hundred thousand cells suspended in 20 muL phosphate-buffered saline were mixed with 200 muL Matrig

228 er-resolution microscopy was demonstrated in phosphate-buffered saline without any reducing or oxidiz

229 g/kg bodyweight intraperitoneal) or vehicle (phosphate-buffered saline) as control.

230 wth and prolonged median survival from 13 d (phosphate-buffered saline) to 20 and 29 d for DAR2 and D

231 Median survival for the groups treated with phosphate-buffered saline, 6 MBq (213)Bi-IMP288, 12 MBq

232 omers enables robust cross-linking in water, phosphate-buffered saline, and cell culture medium to af

233 be delivered in a commercial moisturizer or phosphate-buffered saline, and do not require barrier di

234 temically administered (64)CuCl2 (74 MBq) or phosphate-buffered saline, and tumor sizes were monitore

235 d stability of these probes were assessed in phosphate-buffered saline, cell culture medium, rat seru

236 emotherapy alone, RF hyperthermia alone, and phosphate-buffered saline, combination therapy with RF h

237 emotherapy alone, RF hyperthermia alone, and phosphate-buffered saline, combination therapy with RF h

238 othelial cells, n = 4) or control treatment (phosphate-buffered saline, n = 4) by means of imaging-gu

239 nction 2 weeks after transplant (hCPC versus phosphate-buffered saline, P<0.03).

240 itro radiotracer stability was determined in phosphate-buffered saline, pH 7.4, and in challenge stud

241 99% radiochemical purity and were stable in phosphate-buffered saline, pH 7.4, for 24 h.

242 s (6.1 +/- 0.5 %ID/cm(3)) when compared with phosphate-buffered saline-challenged animals (4.6 +/- 0.

243 tumor growth compared with mice treated with phosphate-buffered saline-containing liposomes (P<0.001)

244 atment groups were compared with age-matched phosphate-buffered saline-injected control transgenic an

245 led animals receiving intravenous vehicle or phosphate-buffered saline-instilled animals receiving me

246 with parstatin compared to their respective phosphate-buffered saline-treated controls.

247 improve muscle regeneration, laminin-111 or phosphate-buffered saline-treated laminin-alpha2-deficie

248 antibody-treated animals lived, whereas 3/8 phosphate-buffered saline-treated mice died.

249 face atherosclerosis was noted compared with phosphate-buffered saline-treated mice.

250 eached as low as 3.5x10(1)CFUmL(-1) in 0.01M phosphate-buffered saline.

251 erapy only, (c) RF hyperthermia only, or (d) phosphate-buffered saline.

252 h; sham controls received an equal volume of phosphate-buffered saline.

253 ce treated with a scrambled-sequence PPMO or phosphate-buffered saline.

254 in all groups were agitated for 3 minutes in phosphate-buffered saline.

255 py alone, (c) RF hyperthermia alone, and (d) phosphate-buffered saline.

256 , nonpretargeted (177)Lu-IMP288 (60 MBq), or phosphate-buffered saline.

257 n 50 muL phosphate-buffered saline or 50 muL phosphate-buffered saline.

258 littermates received intraperitoneal nIgM or phosphate-buffered saline/bovine serum albumin/immunoglo

259 alone (200 million cells, n=5), or placebo (phosphate-buffered saline; n=5) was injected into the in

260 56days in various media: pH5.5, 6.5, and 7.4 phosphate buffered-saline (PBS) containing 0.02% Tween 8

261 y of these spots was detected at the aqueous phosphate buffer/SLG interface by SECM, in both generati

262 ms well for the quantification of glucose in phosphate buffer solution (0.25M PBS, pH 7.0), with a li

263 All the experiments were carried out in 0.1M phosphate buffer solution (PBS) at pH 7.0 and 0.1M KCl s

264 Ru(NH3)6(3+), and anionic Fe(CN)6(4-)) in a phosphate buffer solution (PBS) containing AFB1, the mag

265 ction of reduced glutathione (GSH) in pH 7.2 phosphate buffer solution (PBS) has been reported.

266 lly, the biosensor performance was tested in phosphate buffer solution (PBS) using B394, B131 and B4

267 (E(0)) of -0.471 V (vs. Ag/AgCl) in a pH 6.5 phosphate buffer solution (PBS).

268 sociation with bovine serum albumin (BSA) in phosphate buffer solution (PBS).

269 Glucose sensing accomplished in a phosphate buffer solution (PBS, pH=7) for ZnO/MWCNT/GCE

270 ity for the oxidation of L-cysteine in 0.1 M phosphate buffer solution (pH 5.0).

271 9 cycles in the presence of 80 mM pyrrole in phosphate buffer solution (pH 6.0) containing 20mM CEF.

272 t from CNTs to 7.4 atom % N-CNTs in a sodium phosphate buffer solution (pH 7.0) with 2.0 mM NADH (sca

273 ith 2U of GALOX, at 35 degrees C, using 50mM phosphate buffer solution (pH 7.0).

274 trochemical measurement of dopamine (DA), in phosphate buffer solution (pH 7.4), with a limit of dete

275 photolysis of the chosen aromatic in aqueous phosphate buffer solution (pH = 7.3), with the consecuti

276 1.3-72.2% range) upon incubation with either phosphate buffer solution at pH 7.4 or in the presence o

277 emical measurements have been carried out in phosphate buffer solution at pH 8.0 in batch mode and lo

278 f hydroquinone as electron mediator and 0.1M phosphate buffer solution of pH 6.5.

279 from 0.2 to 1.3V using CV and DPV methods in phosphate buffer solution with pH 2.0.

280 se in phosphate-buffered saline (PBS) (50 mM phosphate buffer solution, pH 7.4, with 150 mM NaCl), hi

281 centration range of 30.4 and 243.9 microM in phosphate buffer solution, with a corresponding limit of

282 PEC) for sustained water splitting in a pH 7 phosphate buffer solution.

283 (GC-Nf-B-3Nf) film modified GCE in a pH 3.5 phosphate buffer solution.

284 ation was observed in organic solvents or in phosphate buffer solution.

285 explored by the electrochemical approach in phosphate buffer solution.

286 dified glassy carbon electrode (MWNT/GCE) in phosphate buffer solution.

287 mical and electrochemical methods in aqueous phosphate buffer solutions (PBS, pH 7.4).

288 immune deficiency virus) antibodies (Ab) in phosphate buffered solutions (PBS).

289 nt (kexp) found in both 1 mM NaHCO3 and 1 mM phosphate-buffered solutions suggested that OH radical w

290 ate) (ABTS) and self-decay of ferrate(VI) in phosphate-buffered solutions.

291 Trypanosoma brucei TryS in a newly developed phosphate buffer system at pH 7.0 and 37 degrees C, mimi

292 ridine) and Na2S2O8, in acetonitrile/aqueous phosphate buffer takes place with a quantum yield of 0.2

293 genise and heat samples in an SDS-containing phosphate buffer to dissolve major muscle components and

294 NADH degradation, known to occur in phosphate buffer, was characterized by absorbance at 340

295 and ferric chloride addition in borate- and phosphate-buffered waters showed that phosphate could se

296 by the buffer system except for citrate and phosphate buffers, which both annihilated anthocyanin-me

297 Replacing the phosphate buffer with 3-(N-morpolino)propane sulfonic ac

298 Capture was performed in phosphate buffer with a fixed optimal concentration of c

299 osensor response for both samples diluted in phosphate buffer with a higher limit of detection for th

300 he freeze dried product in Mcllvaine citrate-phosphate buffers with pH values of 3-5 and temperatures